LJPC-0118 | Friends of Cancer Research

You are here

LJPC-0118

Sponsor: 
La Jolla Pharmaceutical Company
Indication: 
Patients with severe malaria
Category: 
Year: 
2019
Date: 
Apr 24th
FDA Status: 
Designation Granted